| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 07/12/2007 | US20070160620 Immune responses using compositions containing stress proteins |
| 07/12/2007 | US20070160618 Cardiotrophin-1 compositions and methods for the treatment of tumor |
| 07/12/2007 | US20070160612 Interleukin-22 polypeptides, nucleic acids encoding the same and methods for the treatment of pancreatic disorders |
| 07/12/2007 | US20070160609 Interferon antagonists useful for the treatment of interferon related diseases |
| 07/12/2007 | US20070160604 Methods of identifying compounds capable of modulating t cell immune responses involving sema4a protein |
| 07/12/2007 | US20070160602 Compositions and methods of using galectin-8 as an inhibitor of tumor cell growth |
| 07/12/2007 | US20070160596 For use as suppressors of cancer, cell or tissue proliferation and of inflammatory disorders |
| 07/12/2007 | US20070160595 Human Tumor Necrosis Factor TR20 and Methods Based Thereon |
| 07/12/2007 | US20070160594 Method of Diagnosing and Treating Cartilaginous Disorders |
| 07/12/2007 | US20070160580 Interferon gamma therapies for idiopathic pulmonary fibrosis |
| 07/12/2007 | US20070160579 Methods of modulating a mammalian cytokine |
| 07/12/2007 | US20070160576 IL-17A/F heterologous polypeptides and therapeutic uses thereof |
| 07/12/2007 | US20070160575 Anth1 chimeric antagonist |
| 07/12/2007 | US20070160574 Design of CXC chemokine analogs for the treatment of human diseases |
| 07/12/2007 | US20070160573 Peptide conjugated anti-cancer prodrugs |
| 07/12/2007 | US20070160572 Colloidal metal compositions and methods |
| 07/12/2007 | US20070160570 Chimeric polypeptides containing chemokine domains |
| 07/12/2007 | US20070160568 Polyamino acids functionalized by at least one hydrophobic group and the therapeutic application thereof |
| 07/12/2007 | US20070160558 Peptide composition |
| 07/12/2007 | US20070160545 Method for reducing ultraviolet light induced apoptosis |
| 07/12/2007 | US20070160535 Neoplasia, ovarian cancer and skin cancer; radiolabelling |
| 07/12/2007 | US20070160534 Conjugate comprising a peptide having an engineered amino acid sequence capable of binding a plasma protein, said peptide conjugated to the therapeutic or diagnostic substance, wherein elimination half time of conjugate exceeds that of unconjugated therapeutic or diagnostic substance; peptide ligands |
| 07/12/2007 | US20070160533 vascular endothelial growth factor receptor (VEGFR)-binding polypeptides, comprising a fibronectin type III tenth (10Fn3) domain of 80 to 150 amino acids; Angiogenesis |
| 07/12/2007 | US20070160531 Targeting endothelium for tissue-specific delivery of agents |
| 07/12/2007 | US20070160530 Antibodies and molecules derived therefrom that bind to steap-1 proteins |
| 07/12/2007 | US20070160526 Detection, monitoring and treatment of cancer |
| 07/12/2007 | CA2674269A1 Three component carbohydrate vaccine |
| 07/12/2007 | CA2646833A1 Peptides useful as cell-penetrating peptides |
| 07/12/2007 | CA2636184A1 Gene promoters that can be used in plants |
| 07/12/2007 | CA2635660A1 Spider silk proteins and methods for producing spider silk proteins |
| 07/12/2007 | CA2635618A1 Interleukin-12p40 variants with improved stability |
| 07/12/2007 | CA2635615A1 Anti-il-6 antibodies preventing the binding of il-6 complexed with il-6ralpha to gp130 |
| 07/12/2007 | CA2635560A1 Chicken virus vaccine and diagnostic |
| 07/12/2007 | CA2634974A1 Extended release of neuregulin for improved cardiac function |
| 07/12/2007 | CA2632918A1 Method for preventing and/or treating articles or media contaminated with bacteria of the legionella genus |
| 07/12/2007 | CA2632826A1 Bacteriocin inducer peptides |
| 07/11/2007 | EP1806407A2 DNA sequences having anti-repressor activity |
| 07/11/2007 | EP1806404A1 Isolated nucleic acid molecules which encode T cell inducible factors, or interleukin-21, the proteins encoded, and uses thereof |
| 07/11/2007 | EP1806403A2 Human cancer antigen NY ESO 1/CAG-3 and gene encoding same |
| 07/11/2007 | EP1806402A2 CTLA4/CD28 ligands and uses therefor |
| 07/11/2007 | EP1806377A1 Temperature-responsive depsipeptide polymer |
| 07/11/2007 | EP1806363A1 METHOD OF DETECTING HEPATITIS B VIRUS s ANTIGEN |
| 07/11/2007 | EP1806362A2 Nucleic acids encoding a G-protein coupled receptor involved in sensory transduction |
| 07/11/2007 | EP1806361A1 Erythropoietin liquid formulation |
| 07/11/2007 | EP1806360A2 Novel expression vectors containing accessory molecule ligand genes and their use for immunomodulation and treatment of malignancies and autoimmune disease |
| 07/11/2007 | EP1806359A1 Tumor-associated peptides binding promiscuously to human leukocyte antigen (HLA) class II molecules |
| 07/11/2007 | EP1806358A2 Tumor-associated peptides binding promiscuously to human leukocyte antigen (HLA) class II molecules |
| 07/11/2007 | EP1806357A1 Hypoxia inducible factor-1 and method of use |
| 07/11/2007 | EP1806146A1 Agonists or antagonists of cutaneous T cell-attracting chemokine (CTACK) or vasoactive intestinal contractor (VIC) chemokines |
| 07/11/2007 | EP1806144A2 Use of SARP-1 for the treatment and/or prevention of scleroderma |
| 07/11/2007 | EP1806143A2 Baff receptor (BCMA), an immunoregulatory agent |
| 07/11/2007 | EP1806142A1 Method for the production of (poly)peptides by using truncated variants of the SV 40 large T antigen with an intact N terminus |
| 07/11/2007 | EP1805511A1 Intraoperative method for isolating and concentrating autologous growth factors and for forming residual autologous growth factor compositions |
| 07/11/2007 | EP1805309A2 C1q related protein |
| 07/11/2007 | EP1805218A2 Compositions and methods for the assay of g-protein coupled receptors and their ligands |
| 07/11/2007 | EP1805217A2 Method for the preparation of oxime, thiazolidine, dithiane, dithiolane or hydrazone linked analogues of growth hormone |
| 07/11/2007 | EP1805216A2 Growth hormone conjugates |
| 07/11/2007 | EP1805215A2 Chemically modified peptide analogs |
| 07/11/2007 | EP1805214A2 T-cell stimulatory peptides from the melanoma-associated chondroitin sulfate proteoglycan and their use |
| 07/11/2007 | EP1805213A2 Peripherally delivered glutamic acid decarboxylase gene therapy for spinal cord injury pain |
| 07/11/2007 | EP1805210A1 Novel peptides and methods for the treatment of inflammatory disease |
| 07/11/2007 | EP1805209A2 Nogo-a polypeptide fragments, variant nogo receptor-1 polypeptides, and uses thereof |
| 07/11/2007 | EP1805204A2 Process for production of bivalirudin |
| 07/11/2007 | EP1804835A2 Multimeric constructs |
| 07/11/2007 | EP1804830A2 Cancer-testis antigens |
| 07/11/2007 | EP1804829A1 T-cadherin antigen arrays and uses thereof |
| 07/11/2007 | EP1804822A1 Hcv vaccines for chronic hcv patients |
| 07/11/2007 | EP1730278A4 Method for preparation and purification of recombinant proteins |
| 07/11/2007 | EP1673625A4 Generation of stabilized proteins by combinatorial consensus mutagenesis |
| 07/11/2007 | EP1664301A4 Novel rat calcium channel subunits and related probes, cell lines and methods |
| 07/11/2007 | EP1565557B1 Mismatch endonucleases and methods of use |
| 07/11/2007 | EP1535065A4 Neuroprotective synergy of erythropoietin and insulin-like growth factor |
| 07/11/2007 | EP1506408A4 Methods for diagnosing htlv-i-mediated diseases |
| 07/11/2007 | EP1496737B1 .ce1, a regulator of cold induced transcriptome and freezing tolerance in plants |
| 07/11/2007 | EP1490087A4 Self-assembling-peptide-based structures and processes for controlling the self-assembly of such structures |
| 07/11/2007 | EP1404877A4 New assays for preimplantation factor and preimplantation factor peptides |
| 07/11/2007 | EP1395829B1 Cancer associated protein |
| 07/11/2007 | EP1370666B1 Genetic immunisation against cervical carcinoma |
| 07/11/2007 | EP1242108B1 Optimized minigenes and peptides encoded thereby |
| 07/11/2007 | EP1237925B1 Mutant er-alpha and test systems for transactivation |
| 07/11/2007 | EP1228228B1 Sorghum dwarfing genes and methods of use |
| 07/11/2007 | EP1218504B1 Gl50 molecules and uses therefor |
| 07/11/2007 | EP1214399B1 High level cytokine production with enhanced cell viability |
| 07/11/2007 | EP1209232B1 Regulating plant branching |
| 07/11/2007 | EP1154788B1 Inhibitors of separin, method for identifying them and uses |
| 07/11/2007 | EP1146889B1 IDENTIFICATION OF SPECIFIC DIFFERENTIALLY EXPRESSED MYCOBACTERIAL ANTIGENS AND MEDICAL USE OF THE MYCOBACTERIAL PROTEINS Rv0068 AND Rv3407 |
| 07/11/2007 | EP1141418B1 Selecting animals for parentally imprinted traits |
| 07/11/2007 | EP1141283B1 NOVEL METHOD FOrR IDENTIFICATION OF A COMPOUND MODULATING INTERACTION BETWEEN A TNF LIGAND AND ITS RECEPTOR ON B CELLS |
| 07/11/2007 | EP1071767B1 Gene coding for heliomicine and use thereof |
| 07/11/2007 | EP1065270B1 HUMAN p51 GENES AND GENE PRODUCTS THEREOF |
| 07/11/2007 | EP1037917B1 Recombinant nodavirus compositions and methods |
| 07/11/2007 | EP0975771B1 Type ii tgf-beta receptor/immunoglobulin constant region fusion proteins |
| 07/11/2007 | EP0904352B1 Cell line |
| 07/11/2007 | EP0808367B1 Mucosal vascular addressins and uses thereof |
| 07/11/2007 | EP0577752B2 Human pf4a receptors and their use |
| 07/11/2007 | CN1997756A Haplotype markers and methods of using the same to determine response to treatment |
| 07/11/2007 | CN1997751A Antibodies and related molecules that bind to PSCA proteins |
| 07/11/2007 | CN1997749A Biomolecule partition motifs and uses thereof |
| 07/11/2007 | CN1997745A Cancer specific promoters |
| 07/11/2007 | CN1997741A Novel mite allergen |